$36.92M | |
$2.32 | |
$245.70 | |
$2.10 | |
$2.30 | |
-- | |
0.00% | |
147K |
Veru Inc. (VERU) is currently trading at $2.30 as of null, reflecting a 0.00% move ($-0.00) from the previous close.
In the short term, the stock has returned -170.94% over the past four weeks. Over the last 12 months, Veru Inc. has recorded a -58.18% price change, indicating a weak performance relative to the broader market.
Over the past seven days, Veru Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $2.24 to the latest recorded price of $2.30, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (146,885), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, VERU has delivered a -170.94% return over the past month and a -58.18% change in the last 12 months, indicating a weak trend relative to its broader sector peers.
You can buy and trade VERU on MEXC in three simple steps:
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 20 |
| Sector | PHARMACEUTICAL PREPARATIONS |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 VERU = 2.3 USD